Veraxa Biotech AG (VRXA)
NGM · Healthcare · Biotechnology
$1.97
-0.51%
Closing price as of 2026-07-29 · Source: TEK2day Finance
1-Year Price History
-88.5% over period
Key Metrics
Annual Financials
| Metric | 2023-12-31 | 2024-12-31 | 2025-12-31 |
| Revenue | 0.00 | 0.00 | 23K |
| Gross Profit | | 0.00 | 15K |
| Operating Income | -16.7M | -28.9M | -66.2M |
| Net Income | -16.5M | -28.1M | -66.6M |
| Diluted EPS | $-0.12 | $-0.21 | $nan |
Want live quotes, estimates, SEC filings, and CEO analytics for VRXA?
The free TEK2day terminal runs in your browser — type /VRXA to get started.
Open VRXA in the Terminal →